JAMA Oncol 2019 Oct 31
Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial.
Related Questions
PUMP-2 trial combined FUDR via HAIP with gemcitabine and cisplatin, no immunotherapy was on the protocol.
New answer by Medical Oncologist at NYU Grossman School of Medicine (November 18, 2024)
Thank you for the question. I agree that the HAIP can be an effective option for carefully selected patients ineligible for resection in the hands of experts experienced with ...